Streetbeat News

Products Services

GFI

Gold Fields shares are trading higher following the announcement of the start of production at its Salares Norte Mine. The stock's rise is also attributed to the recent strength in gold prices.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 11:48 am

AMZN

GOOG

MSFT

ONLN

XLY

Amazon AWS introduced Deadline Cloud, a service for the media and entertainment industry to facilitate rendering pipelines using AWS cloud. This service aims to meet the growing demand for high-quality rendering and generative AI content. AWS competes with Microsoft and Alphabet's Google in the cloud computing market. AWS's expansion includes a $10B investment in Mississippi and plans for data center expansions in Mexico and Japan. AMZN stock is slightly down in premarket trading, while exposure to AMZN can also be gained through XLY and ONLN ETFs.

Portfolio Pulse from Anusuya Lahiri

April 03, 2024 | 11:45 am

GFI

Gold Fields announced the commencement of production at its Salares Norte mine in Chile's Atacama Province, with the first gold-silver dore poured on March 28, 2024. This development was disclosed in an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 11:42 am

PHIO

Phio Pharmaceuticals announced that its INTASYL platform will be featured on 'Viewpoint', a national program hosted by Dennis Quaid. This exposure could potentially increase awareness and interest in Phio Pharmaceuticals' innovative technology.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 11:34 am

VERO

Venus Concept announced it has received clearance from the Therapeutic Goods Administration in Australia to market its Venus Versa Pro System, a significant milestone for the company's expansion in the Australian market.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 11:34 am

ABIO

ARCA biopharma and Oruka Therapeutics have announced a merger agreement, aiming to create a company focused on advancing Oruka's novel biologics for chronic skin diseases. The deal, expected to close in Q3 of 2024, will support the development of ORKA-001 and ORKA-002 into clinical trials by 2025, with a pre-closing private financing of approximately $275 million to fund operations through 2027.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 11:32 am

SNGX

Soligenix has reached an agreement with the European Medicines Agency (EMA) on the design of a second confirmatory placebo-controlled trial for HyBryte, a treatment under development.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 11:31 am

FEAM

5E Advanced Materials has started commercial production at its 5E Boron Americas Complex, leading to an increase in its share price.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 11:30 am

SGHT

Sight Sciences shares surged following the announcement that data from studies on its glaucoma and dry eye technologies will be presented at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 11:26 am

GKOS

The U.S. Centers for Medicare and Medicaid Services has assigned a unique, permanent J-code for Glaukos' iDose TR (Travoprost Intracameral Implant) 75 mcg, aimed at reducing intraocular pressure. This development is significant for Glaukos as it facilitates billing and reimbursement processes for their product, potentially increasing its accessibility and usage.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 11:25 am